Adma Biologics Inc’s filing revealed that its Director Guiheen Lawrence P. unloaded Company’s shares for reported $0.17 million on Sep 09 ’24. In the deal valued at $18.47 per share,9,000 shares were sold. As a result of this transaction, Guiheen Lawrence P. now holds 153,941 shares worth roughly $2.94 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Guiheen Lawrence P. bought 9,000 shares, generating $146,340 in total proceeds.
Before that, Kestenberg-Messina Kaitlin M. sold 24,150 shares. Adma Biologics Inc shares valued at $408,050 were divested by the COO and SVP, Compliance at a price of $16.90 per share. As a result of the transaction, Kestenberg-Messina Kaitlin M. now holds 449,088 shares, worth roughly $8.58 million.
A number of analysts have revised their coverage, including Mizuho’s analysts, who began to cover the stock in mid October with a ‘”a Buy”‘ rating. Raymond James also remained covering ADMA and has increased its forecast on November 11, 2021 with a “Strong buy” recommendation from previously “an Outperform” rating. Cantor Fitzgerald started covering the stock on November 09, 2021. It rated ADMA as “an Overweight”.
Price Performance Review of ADMA
On Monday, Adma Biologics Inc [NASDAQ:ADMA] saw its stock fall -1.34% to $19.11. Over the last five days, the stock has gained 16.31%. Adma Biologics Inc shares have risen nearly 322.79% since the year began. Nevertheless, the stocks have risen 453.91% over the past one year. While a 52-week high of $21.13 was reached on 10/09/24, a 52-week low of $3.40 was recorded on 01/03/24. SMA at 50 days reached $17.89, while 200 days put it at $11.17.
Levels Of Support And Resistance For ADMA Stock
The 24-hour chart illustrates a support level at 18.86, which if violated will result in even more drops to 18.60. On the upside, there is a resistance level at 19.46. A further resistance level may holdings at 19.80. The Relative Strength Index (RSI) on the 14-day chart is 61.65, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 1.69, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 22.06%. Stochastics %K at 71.31% indicates the stock is a holding.
How much short interest is there in Adma Biologics Inc?
A steep rise in short interest was recorded in Adma Biologics Inc stocks on 2024-10-15, growing by 3.65 million shares to a total of 16.07 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-13 was 12.42 million shares. There was a rise of 22.72%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on June 04, 2019 when Jefferies began covering the stock and recommended ‘”a Buy”‘ rating along with a $8 price target.
